OHSU turns a year of operating loss into a positive margin
Portland-based Oregon Health & Science University closed fiscal year 2026 with an operating income of $135 million, equal to a 2.2% operating margin, after posting an operating loss of $118 million and a negative 2.1% margin in fiscal 2025. The swing is meaningful not just because it moved the system back into black ink, but because it came alongside broad-based revenue expansion, disciplined expense growth and a tighter grip on operations across the enterprise.
Net income climbed to $512 million in fiscal 2026 from $74 million a year earlier. Operating revenue rose to $6.3 billion from $5.5 billion, while operating expenses increased to $6.2 billion from $5.6 billion. In a health system environment where labor, supplies and reimbursement pressure continue to compress margins, the gap between revenue growth and expense growth often decides whether a system can absorb volatility or slide back into deficit.
Volume, acuity and oncology drove the top line higher
The strongest operating gains came from the core business. Net patient revenue increased 20.3% year over year, powered by 10.2% volume growth and another 10.1% from acuity, collections and rates. Clinical revenue growth of 18.5% outpaced expense growth of 9.4%, creating the spread that supported the return to positive operating income.
Cancer services rose 30%, a notable contribution in a sector where high-acuity service lines frequently carry both clinical and financial weight. Case-mix index increased 3.5%, suggesting a more complex patient mix and higher resource intensity per discharge. In practical terms, a stronger case mix can raise reimbursement when documentation and coding capture severity accurately, but it also forces the organization to manage staffing, throughput and supply utilization more carefully.
Full-time equivalent growth was held to 2%, a sign that leadership kept labor expansion well below the pace of revenue growth. Supply chain and revenue cycle initiatives also contributed to the improvement. Those levers matter because even strong patient volume can fail to translate into margin if claims lag, denials rise or procurement costs outrun reimbursement.
The margin rebound was not an accident of accounting. It reflected a tighter clinical operation supported by better throughput, better collections and a service mix that generated more revenue per unit of activity.
Investment returns and foundation gains amplified the bottom line
Nonoperating gains added a substantial lift to the overall results. OHSU recorded $203 million in investment returns and $148 million in gains from its interest in the OHSU Foundation. Together, those items helped widen net income far beyond the operating result.
For a large academic health system, investment performance can soften the blow of operating pressure, but it can also mask how dependent the enterprise remains on market conditions outside the hospital walls. A stronger operating margin is more durable than a one-year uplift from portfolio gains because it comes from the patient-facing business itself. When operations are healthy, investment income becomes a buffer rather than a crutch.
Liquidity improved while debt stayed relatively flat
Cash position strengthened during the year. OHSU held 139 days cash on hand as of June 30, 2026, up from 133 days a year earlier, and cash and investments increased by $140 million. Long-term debt remained relatively flat at $1.3 billion.
Those figures suggest a system that improved liquidity without taking on a major new debt load. Days cash on hand is one of the clearest indicators of how long a system can cover payroll, debt service and operating needs if reimbursement slows or costs spike. A rise of six days may not sound dramatic, but in hospital finance it can signal more breathing room for capital planning, bond covenant stability and resilience against short-term shocks.
Affiliation exit costs and support for Hillsboro Medical Center weighed on expenses
Not every expense line moved in OHSU’s favor. The system booked about $22 million in costs tied to ending its integrated health system affiliation with Roseville, Calif.-based Adventist Health. The two organizations signed a termination agreement Nov. 7, 2025, and OHSU agreed to pay Adventist $23 million in two installments of $11.5 million due June 30, 2026, and June 30, 2027.
That kind of separation cost can be easy to miss in a headline margin story, but it affects real cash flow and management attention. Disentangling system relationships often requires legal, operational and financial work that does not directly generate patient revenue.
OHSU also provided $15 million in operating support to Hillsboro Medical Center in fiscal 2026 and recorded a full reserve against a $19.6 million capital loan to the hospital. The reserve signals caution around collectability and reinforces how regional support arrangements can become financial liabilities when a partner hospital remains fragile. For academic systems with community obligations, these commitments can advance access and stabilize care, yet they also consume capital that might otherwise have been directed toward growth initiatives or debt reduction.
Why the FY 2026 rebound matters for hospital operators
The combination of higher volume, stronger acuity and controlled staffing produced the operating turnaround. In hospital finance, those ingredients often determine whether a system can fund the next year’s wage pressures, technology upgrades and service-line investments without leaning too heavily on market gains or one-time items.
A 2.2% operating margin does not leave much cushion. It is positive, but it remains thin relative to the volatility that health systems face from payer mix changes, labor shortages, pharmacy costs and delayed reimbursement. Even so, OHSU’s FY 2026 performance shows that disciplined execution across revenue cycle, supply chain and clinical operations can still move a large academic health system from loss to profit in a single year.
The more difficult test comes next: preserving that margin while absorbing affiliation costs, supporting vulnerable community partners and keeping revenue growth ahead of expense growth in a less forgiving cycle.